关键信息
-
基因名
PNKD
- 应用
-
别名
2210013N15Rik; 2810403H05Rik; AI854243; BRAIN PROTEIN 17; BRP17; DYT8; FKSG19; FPD1; KIAA1184; KIPP1184; MNCb-5687; MR-1; MR1; Myofibrillogenesis regulator 1; Paroxysmal nonkinesiogenic dyskinesia protein; PDC; PKND1; Pnkd; PNKD_HUMAN; Probable hydrolase PNKD; TAHCCP2; Trans-activated by hepatitis C virus core protein 2
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8N490
-
表达区间
1-385 aa
-
氨基酸序列
MAAVVAATAL KGRGARNARV LRGILAGATA NKASHNRTRA LQSHSSPEGK EEPEPLSPEL EYIPRKRGKN PMKAVGLAWY SLYTRTWLGY LFYRQQLRRA RNRYPKGHSK TQPRLFNGVK VLPIPVLSDN YSYLIIDTQA QLAVAVDPSD PRAVQASIEK EGVTLVAILC THKHWDHSGG NRDLSRRHRD CRVYGSPQDG IPYLTHPLCH QDVVSVGRLQ IRALATPGHT QGHLVYLLDG EPYKGPSCLF SGDLLFLSGC GRTFEGNAET MLSSLDTVLG LGDDTLLWPG HEYAEENLGF AGVVEPENLA RERKMQWVQR QRLERKGTCP STLGEERSYN PFLRTHCLAL QEALGPGPGP TGDDDYSRAQ LLEELRRLKD MHKSK
-
分子量
42.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
PNKD (pathological neurodegeneration kinase domain) is a gene implicated in various neurodegenerative disorders, particularly those associated with abnormal protein aggregation and synaptic dysfunction. Research into PNKD has gained momentum due to its potential role in the pathogenesis of conditions like Parkinson’s disease, Alzheimer’s disease, and other movement disorders. The protein product of PNKD is believed to participate in cellular signaling pathways that regulate neuronal survival and apoptosis, making it a critical target for therapeutic intervention. Studies have demonstrated that mutations in the PNKD gene can lead to altered kinase activity, affecting neuronal health and morphology. Consequently, the production of recombinant PNKD proteins is of significant interest, as these proteins can be utilized to elucidate the structural and functional aspects of PNKD, assess the biochemical pathways it influences, and explore the impact of mutations on its functionality. By generating and characterizing PNKD recombinant proteins, researchers aim to establish a clearer understanding of its role in neurodegeneration and to identify potential therapeutic strategies that could mitigate the effects of PNKD-related pathologies. In summary, the investigation of PNKD recombinant proteins is crucial for advancing our knowledge of neurodegenerative diseases and for the development of targeted therapies.
